Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.60    -0.025 (-4.00%)
Bid:
0.55
Ask:
0.65
Spread: 0.10 (18.182%)
Market Cap: £2.72m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Conversion of Loan Note

18 Dec 2009 13:06

RNS Number : 3955E
Physiomics PLC
18 December 2009
 



Physiomics plc

(the "Company")

Conversion of Loan Note

The Company announces that pursuant to the terms of a loan note dated 8 February 2008 and made between (i) Energiser Investments plc and (ii) the Company, (the "Loan Note"), Energiser Investments plc has requested that the full amount drawn down under the Loan Note be converted into ordinary shares in the Company.

Under the Loan Note, which was announced to the market on 15 February 2008, Energiser Investments plc (formerly Billam plc) advanced £50,000 to the Company, which is convertible into ordinary shares at a price of 0.1p per share.

The total number of shares to be issued to Energiser Investments plc, pursuant to the terms of the loan note, is therefore 50,000,000 Ordinary Shares (the "Conversion Shares")

Application has been made to admit the Conversion Shares to trading on AIM, and dealings in the Conversion Shares is expected to commence on 24 December 2009. Following the issue of the Conversion Shares, the total issued share capital of the Company will be 998,570,699 Ordinary Shares.

On 9 December 2009 it was announced that Energiser Investments plc then held 100,004 ordinary shares in the Company. Following the issue of the Conversion Shares and taking into account the holding notified on 9 December 2009, Energiser Investments plc will hold 50,100,004 Ordinary Shares in the Company, representing 5.017% of the then issued share capital. 

Enquiries:

Physiomics plc

Dr Christophe Chassagnole, COO 

+44 (0)1865 784980

WH Ireland Limited

Katy Mitchell

+44 (0161 832 2174

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGMMZFRDGLZM
Date   Source Headline
13th Dec 20217:00 amRNSMerck Contracts
23rd Nov 20213:30 pmRNSResult of AGM
12th Nov 202112:00 pmRNSConference presentation
12th Nov 202112:00 pmRNSConference presentation
27th Oct 20211:00 pmRNSPosting of Annual Report and AGM Notice
22nd Oct 20217:00 amRNSContract awards
30th Sep 20213:00 pmRNSResults Presentation and DoseMeRx Update
30th Sep 20217:00 amRNSFinal Results
16th Sep 20212:45 pmRNSPARNTER study recruits first patient
15th Sep 20217:00 amRNSNotice of Results and Investor Presentation
31st Aug 20217:00 amRNSPhysiomics hires Head of Business Development
19th Jul 20217:00 amRNSPhysiomics expands technical team
29th Jun 20219:16 amRNSDirector Dealing
21st May 20214:40 pmRNSDirector Dealing
21st May 20217:00 amRNSContract awards
14th May 20217:00 amRNSContract award
11th May 20217:00 amRNSContract award
10th May 20217:00 amRNSTrading update
9th Apr 20212:00 pmRNSConference presentation
22nd Mar 20217:00 amRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSPresentation and Q&A on Company's Interim Results
4th Mar 20217:00 amRNSInterim Results Presentation
2nd Mar 202110:12 amRNSIssue of Options
1st Mar 20217:00 amRNSInterim Results
15th Feb 20217:00 amRNSValiRx Agreement
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20202:00 pmRNSPartnership with TRHC's DoseMeRx®
17th Dec 20207:00 amRNSMerck Contracts
14th Dec 20207:00 amRNSApproval of NIHR-funded PARTNER study
17th Nov 202012:59 pmRNSResult of AGM
22nd Oct 20208:30 amRNSPosting of Annual Report and AGM Notice
22nd Oct 20207:00 amRNSPosting of Annual Report and AGM Notice
16th Oct 20207:00 amRNSContract awards
6th Oct 20209:00 amRNSPresentation and Q&A on Company’s Final Results
30th Sep 20207:00 amRNSFinal Results and Notice of AGM
25th Sep 20207:00 amRNSFull year results release date and shareholder Q&A
11th Sep 20207:00 amRNSHolding(s) in Company
12th Aug 20207:00 amRNSDirector Dealing
5th Aug 20201:00 pmRNSIssue of Equity
5th Aug 20207:00 amRNSIssue of Equity and Director Dealing
4th Aug 20207:00 amRNSTrading update
31st Jul 20207:00 amRNSPhysiomics awarded contract by Astellas Pharma Inc
22nd Jul 202011:45 amRNSShare Price Movement
17th Jul 20209:00 amRNSPrice Monitoring Extension
6th Jul 202010:00 amRNSDirector dealing
30th Jun 20202:30 pmRNSContract award and update
22nd Jun 20207:00 amRNSConference presentation
10th Jun 20201:00 pmRNSHolding(s) in Company
27th May 20207:00 amRNSFundraise
15th May 20201:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.